EBIT: Income before interest and taxes.
Avenue Therapeutics, Inc. (ATXI) had EBIT of $-0.71M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-0.69M |
|
-- |
|
-- |
|
$0.71M |
|
$-0.71M |
|
$0.02M |
|
$-0.69M |
|
$-0.69M |
|
$-0.69M |
|
$-0.69M |
|
$-0.69M |
|
$-0.69M |
|
|
EBIT |
$-0.71M |
$-0.71M |
|
3.29M |
|
3.29M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$2.47M |
|
-- |
|
-- |
|
$2.47M |
|
$1.27M |
|
-- |
|
-- |
|
$1.27M |
|
$1.20M |
|
$1.20M |
|
$1.20M |
|
3.29M |
|
| Cash Flow Statement Financials | |
$-0.44M |
|
-- |
|
-- |
|
$2.85M |
|
$2.42M |
|
$-0.44M |
|
$0.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.94 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.44M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-58.01% |
|
-58.01% |
|
-28.16% |
|
-58.01% |
|
$0.36 |
|
$-0.13 |
|
$-0.13 |
|